When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Anaemia of chronic disease

Last reviewed: 23 Jan 2025
Last updated: 11 Oct 2024

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • systemic symptoms of underlying condition
  • absent history of bleeding
  • physical finding suggesting infection
  • physical finding suggesting neoplasm
  • physical finding suggesting autoimmune disorder
Full details

Other diagnostic factors

  • absent history of high alcohol intake
  • absent history of exposure to chemicals and radiation
  • absent history of drugs known to be associated with risk of anaemia
  • absent history of poor nutrition
  • decreased exercise tolerance
  • shortness of breath with exercise
  • fatigue
  • pallor
Full details

Risk factors

  • autoimmune disorders
  • malignancy
  • acute or chronic infection
  • critical illness, major trauma, or major surgery with delayed recovery
  • chronic disease
Full details

Diagnostic investigations

1st investigations to order

  • Hb
  • WBC and differential
  • platelet count
  • mean corpuscular volume (MCV)
  • mean corpuscular haemoglobin concentration (MCHC)
  • peripheral blood smear
  • serum ferritin
  • serum iron
  • total iron-binding capacity
  • transferrin saturation
  • absolute reticulocyte count
  • serum creatinine
Full details

Investigations to consider

  • C-reactive protein (CRP)
  • erythrocyte sedimentation rate
  • serum B12
  • serum folate
  • thyroid function tests
  • LFTs
  • indirect and direct bilirubin
  • LDH
  • erythropoietin
  • haemoglobin electrophoresis
  • bone marrow biopsy
  • soluble transferrin receptor
  • ratio of soluble transferrin receptor to log ferritin
Full details

Treatment algorithm

ACUTE

mild to moderate anaemia (haemoglobin [Hb] 80 to 110 g/L [8 to 11 g/dL])

severe (Hb <80 g/L [<8 g/dL]) or life-threatening (Hb <65 g/L [<6.5 g/dL]) anaemia

Contributors

Authors

Marina Beltrami Moreira, MD

Assistant Professor

The Ohio State University Wexner Medical Center

The Ohio State University College of Medicine

Columbus

OH

Disclosures

MBM has a pending research grant from the Pfizer-NCCN grant programme.

Acknowledgements

Dr Marina Beltrami Moreira would like to gratefully acknowledge Dr Eric Kraut, Dr Marium Husain, Dr Alice Ma, Dr Damon Houghton, Dr Marco Giovannini, Dr Pasquale Niscola, Dr Karen D. Serrano, Dr Robert D. Woodson, and Dr Kiranveer Kaur, previous contributors to this topic. EK, MH, AM, DH, MG, PN, KDS, RDW, and KK declare that they have no competing interests.

Peer reviewers

Sean R. Lynch, MD

Professor of Clinical Medicine

Eastern Virginia Medical School

Norfolk

VA

Disclosures

SRL declares that he has no competing interests.

Christopher Pechlaner, MD

Associate Professor of Medicine

Innsbruck Medical University

Innsbruck

Austria

Disclosures

CP declares that he has no competing interests.

Robert Chen, MD

Hematology/Oncology Fellow

Department of Medical Oncology

University of Colorado Health Sciences Center

Denver

CO

Disclosures

RC declares that he has no competing interests.

Brady Stein, MD

Associate Professor of Medicine

Northwestern University

Evanston

IL

Disclosures

BS declares that he has no competing interests.

  • Differentials

    • Iron deficiency anaemia
    • Iron deficiency anaemia co-existing with ACD
    • Anaemia associated with chronic renal disease (erythropoietin deficiency)
    More Differentials
  • Guidelines

    • NCCN clinical practice guidelines in oncology: hematopoietic growth factors
    • Chronic kidney disease: assessment and management
    More Guidelines
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer